Clinical Trial Information
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long term efficacy and safety of mirikizumab in Patients with Crohn's Disease- Protocol Number: 12658
- Status: Open
- Treatment Type: Treatment
- Secondary Protocol No.: I6T-MC-AMAX
- Phase: III
- NCT ID: NCT04232553
Scope Information
- Disease Site(s):
- Other